629
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Biologic agents in nail psoriasis: efficacy data and considerations

, &
Pages 1707-1714 | Published online: 25 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kristian Reich, Curdin Conrad, Lars Erik Kristensen, Saxon D. Smith, Luis Puig, Phoebe Rich, Christophe Sapin, Thorsten Holzkaemper, Uffe Koppelhus & Christopher Schuster. (2022) Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis. Journal of Dermatological Treatment 33:3, pages 1652-1660.
Read now

Articles from other publishers (8)

Tainá Kreutz, Sheila Porto de Matos & Letícia Scherer Koester. (2020) Recent Patents on Permeation Enhancers for Drug Delivery Through Nails. Recent Patents on Drug Delivery & Formulation 13:3, pages 203-218.
Crossref
Alan Menter, Bruce E. Strober, Daniel H. Kaplan, Dario Kivelevitch, Elizabeth Farley Prater, Benjamin Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena N. Rupani, Michael Siegel, Emily B. Wong, Jashin J. Wu, Vidhya Hariharan & Craig A. Elmets. (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Journal of the American Academy of Dermatology 80:4, pages 1029-1072.
Crossref
Aikaterini Tsentemeidou, Timoleon-Achilleas Vyzantiadis, Aikaterini Kyriakou, Dimitrios Sotiriadis & Aikaterini Patsatsi. (2017) Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study. Mycoses 60:12, pages 830-835.
Crossref
Monica Joshi, Vijay Sharma & Kamla Pathak. (2015) Nail psoriasis: An updated review of clinical reports on therapy and formulation aspects for topical delivery. Journal of Drug Delivery Science and Technology 30, pages 63-73.
Crossref
R.G. Langley, P. Rich, A. Menter, G. Krueger, O. Goldblum, Y. Dutronc, B. Zhu, H. Wei, G.S. Cameron & M.P. Heffernan. (2015) Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 29:9, pages 1763-1770.
Crossref
Matilde Iorizzo. (2015) Tips to Treat the 5 Most Common Nail Disorders. Dermatologic Clinics 33:2, pages 175-183.
Crossref
Aikaterini Kyriakou, Aikaterini Patsatsi, Timoleon-Achilleas Vyzantiadis & Dimitrios Sotiriadis. (2014) Serum Levels of TNF- α , IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study . The Scientific World Journal 2014, pages 1-5.
Crossref
Aikaterini Kyriakou, Aikaterini Patsatsi, Timoleon-Achilleas Vyzantiadis & Dimitrios Sotiriadis. (2014) Serum Levels of TNF- ? , IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity . Journal of Immunology Research 2014, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.